Cystic Fibrosis vs Kartagener syndrome

All material is copyrighted and the property of mehlmanmedical.

Copyright © 2020 mehlmanmedical.

Privacy Policy and Terms and Conditions


Cystic fibrosis (CF)

Cystic fibrosis likely wins the award for most frequently tested condition on USMLE Step1. Know all of the information printed in this entry regarding this disease. In fact, this entry is probably worth an actual five points on your Step 1.

Inheritance

  • Autosomal recessive
  • Chromosome 7
  • Classically caused by a deletion (ΔF508; deletion of phenylalanine) in the CFTR gene, which normally codes for CFTR protein (cystic fibrosis transmembrane regulator). There are many potential mutations; this is merely just the most HY.
  • CF is the most common genetic disease leading to ↓ lifespan in the Caucasian population.
How to break a 260 on Step 1:

CFTR is a cAMP-regulated and ATP-gated chloride channel.

cAMP activates protein kinase A, which catalyzes the ATP hydrolysis.

CFTR has twelve transmembrane components; two domains, each with six segments (completely outrageous and ridiculous).

How the disease works (this mechanism is really really HY!)

  • CFTR is a transmembrane chloride channel that normally absorbs Cl in sweat but secretes it everywhere else (i.e., pancreas, lungs).
  • Failure to secrete Cl from the pancreas and lungs leads to a buildup of Cl inside the pancreatic acinar cells and alveolar cells, respectively.
  • Buildup of intracellular chloride means increased negative charge inside the cell.
  • In order to balance charge, extracellular sodium within the pancreatic ducts and alveoli moves into the cell via ENaC to balance intracellular charge.
  • Since H2O follows Na+, ↑ H2O reabsorption leads to viscous luminal secretions.
  • This desiccation (drying up) is called inspissation.
  • This is why there are thickened secretions in CF.

Your next question might be, “Well that’s great, but how the fuck does the USMLE actually test that?”

Great, I’ll tell you:

You’ll literally get a question that sounds like CF (discussed below), then they’ll simply ask you for which mechanism regarding ion shift occurs in CF, and the answer is ↑ activation of ENaC.

You need to know where the misfolded channel ends up

One of the highest yield points regarding cystic fibrosis is that mutated CFTR leads to the production of CFTR channel that is retained as a misfolded protein in the rough endoplasmic reticulum (RER).

The USMLE is obsessed with asking about this. “Defective chloride channel found in cell membrane” is 100% the WRONG answer.

Now clearly the RER is in the cytosol, so occasionally the answer might also be “misfolded protein sequestered in cytosol.” You get the point.

There is one special case that is an exception that I discuss in treatments below.

Things move the opposite direction in the sweat glands

  • Whereas Cl is secreted in the pancreas and alveoli, it’s reabsorbed in the sweat glands.
  • Normal sweat losses are hypotonic. In CF, they’re isotonic.
  • This leads to ECF (extracellular fluid) contraction because failure of ↑ in ECF tonicity fails to draw out ICF (intracellular fluid) to compensate.
  • The contraction stimulates RAAS (renin-angiotensin-aldosterone system).
  • ↑ aldosterone-mediated distal renal K+ & H+ wasting can lead to contraction alkalosis.
If they ask about which diuretics can cause effects similar to CF, the answer is loop diuretics.

An extremely HY factoid regarding diagnosis

  • Diagnosis is made via sweat chloride testing indicating > 60 mEq/L  of chloride in the sweat.
  • The sweat Cltest is more diagnostic of CF than genotyping.
You might say, “Well how the fuck is that possible? How could anything be more accurate than having evidence of the mutation in the gene itself?”

This is because the CFTR gene can incur a myriad of mutations that lead to disease (allelic heterogeneity; different disease alleles can cause same disease), thereby ↓ sensitivity (↑ false-negatives) of genotyping.

In other words, there are so many possible mutations that can cause CF that genetic laboratories often run “common panels,” which will screen for the most frequent mutations spanning, e.g., 90-96% of known CF mutations. In contrast, sweat chloride is 100% accurate. If a patient has CF, he or she will almost certainly have a positive sweat chloride test.

  • Neonates can be screened for a positive blood immunoreactive trypsinogen.
  • If positive, the neonate requires a confirmatory sweat chloride test, where topical pilocarpine (muscarinic agonist) stimulates the sweat secretion.
  • Rarely in patients who have a non-diagnostic sweat chloride test and negative genotyping, a nasal transepithelial potential difference (TEPD) test can be performed.

In CF, there is a more negative transepithelial potential difference

  • TEPD merely refers to the charge gradient between the external and internal cell surfaces of respiratory epithelium.
  • Since Na+ is reabsorbed, less positive charge remains on the external cell surface, thereby causing the transepithelial potential difference to be more negative.
  • A nasal TEPD <40 mV is considered positive.

Pulmonary manifestations

  • Cystic fibrosis is associated with increased frequency of pulmonary infections. Although various organisms can cause infection, Pseudomonas and Staph infections are notably more common.
How to break 260 on Step 1:

Pseudomonas is the answer as the most likely organism if over age 10.

Under age 10, S. aureus exceeds Pseudomonas.

The frequencies cross at age 10.

In other words: 8-year-old with CF has pneumonia. Most likely organism? Answer = S. aureus, not Pseudomonas. Woah, craziness.

  • Cystic fibrosis is the most common cause of bronchiectasis in the USA. Bronchiectasis can cause clubbing. So CF is often associated with clubbing.
  • Nasal polyps are often seen in patients with CF. (Seemingly weird detail that is exceedingly HY)

Exocrine pancreas insufficiency causes fat-soluble vitamin malabsorption

  • Since the pancreatic secretions are inspissated, pancreatic enzyme secretion is less efficient and signs of malabsorption are common.
  • Fat-soluble vitamin (A, D, E, K) and B12 deficiencies are common. (All of those blue vitamins link to unique posts btw)
  • So be on the lookout for any symptoms of those nutrient deficiencies, e.g., nyctalopia (A), rickets (D), hemolysis (E), ↑ PT/aPTT (K), megaloblastic anemia (B12), and neurological findings (E and B12).

Endocrine pancreas insufficiency can cause diabetes mellitus

  • Diabetes mellitus is one of the most common morbidities of CF, occurring in ~20% by adolescence and ~40-50% by adulthood.
  • (Obtained those %s from this highly cited American Diabetes Association article here)

Failure to pass meconium in the first 24 hours of life is super HY

  • Failure to pass meconium in the first 24 hours of life is most commonly due to cystic fibrosis (and less commonly Hirschsprung disease).
  • In CF, this failure to pass meconium is given a special name called meconium ileus, where inspissated meconium plugs the ileum.

Some notable treatments for CF

  • N-acetylcysteine softens mucous (N-acetylcysteine has an –SH that reacts with -S–S- bonds in mucous).
  • Guaifenesin ↑ expectoration / clearance of mucous.
  • Dornase-α is a recombinant deoxyribonuclease that breaks down DNA left over from leukocytic debris within mucous. It’s important to associate CF with lots of nucleic acid plugging the airways.

Ivacaftor is a special drug you must know

  • One type of mutation leading to CF, the G551D missense mutation, leads to a glycine that is replaced by an aspartic acid at position 551.
  • This enables the CFTR channel to make it to the cell surface, in contrast to sequestration in the RER/cytosol.
  • The CFTR channel is still defective; it’s just merely at the correct location on the cell surface.
  • Ivacaftor is a CFTR modulator that binds to this misfolded channel and increases the probability it will open.

USMLE likes to ask a couple weird genetics questions about CF

  • We already talked about how CF is AR and and CFTR gene is on chromosome 7.
  • However the USMLE wants you to know that if a phenotypically normal patient has a sibling with an AR condition (e.g., CF) when both parents are carriers, his or her chance of being a carrier is TWO-THIRDS. And further, two people in this category mating would have a one-ninth chance of having a child with an AR condition.
If someone who is phenotypically normal (i.e., does not have the disease) has a sibling with an AR disorder (e.g., CF), there is a 2/3 chance he or she is a carrier because it’s impossible he or she is “aa” if phenotypically normal. Got it?
Guy has a sibling with CF. His wife does not have a family history. The carrier rate in the general population is 1/50. What is the chance they have a child with CF?

  • His chance of being a carrier is 2/3
  • Her chance is 1/50
  • (2/3)(1/50) chance they both are carriers x 1/4 chance their kid would be “aa” = (2/3)(1/50)(1/4) = 1/300 chance.

Not bad right? But if you didn’t know about this 2/3 “factoid” beforehand, you’d be sitting there on the real exam like, “Wait, wtf, why is this weird. Let me think about this shit.”

  • If you get a question where they tell you someone with CF has two copies of an “exceedingly rare” mutation no one’s ever heard of, and they want to know the mechanism for disease, the answer = uniparental isodisomy.
  • This means the individual somehow got two copies of the same allele from the same parent.
  • They will also list uniparental heterodisomy as an answer (receiving two different alleles from the same parent), but this can’t be correct because if this were the case, the parent would also have the disease.
  • If you have two copies of an allele that is “one in ten-million,” it’s absurdly unlikely each parent carried that allele and passed it.

CBAVD and CF

  • Another really important point is cystic fibrosis in relation to infertility.
  • Cystic fibrosis is known to cause congenital bilateral absence of the vas deferens (CBAVD) in men.
  • Even asymptomatic carriers have an increased likelihood of CBAVD and infertility.
  • Because the vas deferens is absent bilaterally, there are NO sperm seen in a sample of ejaculate.

Kartagener syndrome (primary ciliary dyskinesia)

The USMLE is obsessed with the contrast between Kartagener syndrome and cystic fibrosis in regard to infertility

  • A disorder characterized by immotile, dysfunctional cilia, resulting in sperm immotility and defective fallopian tube-mediated ovum transport.
  • This leads to male and female infertility, as well as increased risk of ectopic pregnancy.
A couple has been unsuccessful achieving pregnancy after 12 months of regular intercourse. The male has a heavy history of respiratory tract infections. His semen sample is analyzed. Are there sperm seen in the sample?

Yes, there are sperm, but they are immotile → Kartagener syndrome

No, there are no sperm seen in the sample. → Cystic fibrosis (CBAVD)

USMLE gets pedantic about the ciliary defect

  • The cilia are immotile because of a dynein arm defect.
  • Dynein is a protein that enables proper ciliary motility.
  • A cilium is composed of a 9+2 arrangement of microtubules.
  • In other words, a cilium is larger than a microtubule.
Electron micrograph of a cross-section of a cilium. You can see the 9 + 2 arrangement of microtubules. The USMLE has been known to show EMs like this.

Kartagener is associated with situs inversus

  • You need to know that Kartagener syndrome is associated with situs inversus, where the internal organs are on the opposite side of the body.
  • They might tell you the apex beat is palpated in the 5th intercostal space, just medial to the right midclavicular line.
If they don’t overtly tell you there is dextrocardia (or full-blown situs inversus), they might show you a CXR with the cardiac shadow on the left side of the image (right side of the body).

Pulmonary infections are characteristic

  • As mentioned under infertility above, another common finding is chronic respiratory tract infections or bronchiectasis, due to impairment of mucociliary clearance.

1. What is the inheritance pattern of cystic fibrosis and what is the chromosome number?

2. Most common mutation seen in CF?

3. What is an important point to note about how CF specifically relates to the Caucasian population?

4. Comment on CFTR regulation in relation to cellular mediators and energy utilization.

5. Comment on CFTR channel’s transmembrane components.

6. Which direction does chloride normally move in the pancreas and lungs, that in turn is defective in CF?

 
 

7. Describe the mechanism for how chloride movement is defective in CF and how this relates to thickened secretions.

8. How does ENaC relate to cystic fibrosis?

9. Comment on the location of the misfolded CFTR channel in relation to the overwhelming majority of people with CF.

10. a) Comment on sweat tonicity in CF vs healthy individuals.

b) What kind of acid-base disturbance does this cause?

c) Which diuretic is often discussed in parallel here?

11. What is the most accurate test for diagnosing CF?

12. How can neonates be screened for CF?

13. Comment on transepithelial potential difference (TEPD) in CF.

14. What is the most common cause of pneumonia in CF?

15. What might we find on head & neck exam in a patient with CF?

16. Child with CF has failure to thrive and bowing of the tibias. Why?

17. What might the fasting glucose be numerically in someone with CF by the time of adolescence or older?

18. Comment on a newborn’s presentation in relation to cystic fibrosis.

19. What is N-acetylcysteine’s role in the treatment of CF?

20. What is the role of Guaifenesin in the treatment of CF?

21. What is the role of Dornase-α in the treatment of CF?

22. What is the role of Ivacaftor in the treatment of CF?

23. If someone who is phenotypically normal (i.e., does not have the disease) has a sibling with an AR disorder (e.g., CF), what is the chance he or she is a carrier?

24. If you get a question where they tell you someone with CF has two copies of an “exceedingly rare” mutation no one’s ever heard of, and they want to know the mechanism for disease, what’s the answer?

25. Comment on male infertility in cystic fibrosis.

26. Comment on male infertility in CF vs Kartagener syndrome.

27. Comment on the structure of cilia.

28. One of your patients has Kartagener syndrome. How does this relate to the physical exam you might perform?